Fig. 6From: Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease designTALEN targeting E7 in SiHa and Caski cells showed reduction in E7 levels. a Schematic representation of TALEN targeting E7. b T7E1 assay showing cut products in both SiHa and CaSki cell lines with TALEN treatment. Further, RT-PCR revealed a reduction in E7 levels in SiHa (c) and CaSki (d) cell linesBack to article page